We are live on ! Find out more
CRHM

CRH Medical Corporation
CRHM

Delisted

CRHM was delisted on the 22nd of April, 2021.

36 hedge funds and large institutions have $105M invested in CRH Medical Corporation in 2019 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 15 increasing their positions, 10 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

50% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 10

7% more capital invested

Capital invested by funds: $97.9M → $105M (+$7.16M)

3% more funds holding

Funds holding: 3536 (+1)

Holders
36
Holders Change
+1
Holders Change %
+2.86%
% of All Funds
0.79%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
3
Increased
15
Reduced
10
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
NCM
1
Nantahala Capital Management
Connecticut
$20.1M +$742K +250,000 +4%
SCM
2
Stadium Capital Management
Connecticut
$15.4M +$2.17M +730,880 +17%
BGC
3
Beutel, Goodman & Co
Ontario, Canada
$13.9M -$161K -54,100 -1%
Morgan Stanley
4
Morgan Stanley
New York
$12.2M +$4.65M +1,568,287 +66%
PRCP
5
Pacific Ridge Capital Partners
Oregon
$7.49M +$948K +319,559 +15%
Stifel Financial
6
Stifel Financial
Missouri
$6.79M -$689 -232 -0%
Connor, Clark & Lunn Investment Management (CC&L)
7
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$6.52M +$172K +57,959 +3%
Wellington Management Group
8
Wellington Management Group
Massachusetts
$6.31M +$1.67M +561,651 +38%
Goldman Sachs
9
Goldman Sachs
New York
$4.55M -$276 -93 -0%
JP Morgan Chase
10
JP Morgan Chase
New York
$3.33M -$161K -54,300 -5%
Renaissance Technologies
11
Renaissance Technologies
New York
$2.11M +$47.2K +15,900 +2%
RA
12
Royce & Associates
New York
$1.46M +$1.01M +342,000 +257%
PP
13
Palladium Partners
Virginia
$821K
D.E. Shaw & Co
14
D.E. Shaw & Co
New York
$780K +$180K +60,700 +31%
UBS Group
15
UBS Group
Switzerland
$564K -$5.87K -1,977 -1%
CAM
16
Claret Asset Management
Quebec, Canada
$503K +$415K +139,716 +587%
SCP
17
Seizert Capital Partners
Michigan
$486K
HIM
18
Hillsdale Investment Management
Ontario, Canada
$470K +$454K +153,000 New
WCM
19
Wedge Capital Management
North Carolina
$303K
TD Asset Management
20
TD Asset Management
Ontario, Canada
$194K -$40.7K -13,705 -18%
Bank of America
21
Bank of America
North Carolina
$160K +$137K +46,044 +767%
Deutsche Bank
22
Deutsche Bank
Germany
$154K -$2.87M -968,574 -95%
QI
23
QS Investors
New York
$146K -$37.7K -12,700 -21%
WSTAM
24
Wilbanks Smith & Thomas Asset Management
Virginia
$108K
Northern Trust
25
Northern Trust
Illinois
$93K +$644 +217 +0.7%

CRHM Hedge Fund Activity: Q3 2019 in Review

36 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in CRH Medical Corporation (CRHM) for Q3 2019, worth a combined $105M — up 7.3% from $97.9M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new CRHM positions and 2 closed out — a net gain of 1 holder — while 15 added to existing stakes and 10 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $4.65M. The largest seller was Canada Pension Plan Investment Board, exiting entirely with an estimated $4.52M sold.

  • 36 institutional investors held CRH Medical Corporation (CRHM) as of Q3 2019, up from 35 in Q2 2019.
  • Funds reported $105M of CRH Medical Corporation stock for Q3 2019, up 7.3% quarter-over-quarter.
  • 3 funds opened new CRH Medical Corporation positions in Q3 2019 and 2 closed out, a net change of +1 holder.
  • The largest CRH Medical Corporation buyer in Q3 2019 was Morgan Stanley, an estimated $4.65M added.
  • The largest CRH Medical Corporation seller in Q3 2019 was Canada Pension Plan Investment Board, an estimated $4.52M sold.

Based on aggregated 13F filings for Q3 2019.